Prostate Cancer
Recent Abstracts
Neurologic Symptoms After 177Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience.
August 5, 2024
Incidence and Pitfalls of Adipose Tissue Encountered in Prostatic Transurethral Resections and Related Specimens.
August 5, 2024
Prostate-Specific Membrane Antigen PET/CT-Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer.
August 5, 2024
LX1 Targets Androgen Receptor Variants and AKR1C3 to overcome Therapy Resistance in Advanced Prostate Cancer.
August 5, 2024
Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study.
August 5, 2024
Incidence of prostate cancer in Medicaid beneficiaries with and without HIV in 2001-2015 in 14 states.
August 2, 2024
The Influence of Disparities on Prostate Cancer at Diagnosis in the Charlotte Metropolitan Area.
August 2, 2024
Artificial intelligence-based personalized clinical decision-making for patients with localized prostate cancer: surgery versus radiotherapy.
August 2, 2024
Antiandrogen Withdrawal Syndrome After Discontinuation of Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer: A Report of Two Clinical Cases and a Literature Review.
August 2, 2024
Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancer.
August 2, 2024
Race-Based Screening under the Public Health Ethics Microscope - The Case of Prostate Cancer.
August 1, 2024
European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy.
August 1, 2024
Early PSA Response by 6 Months is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of TITAN Trial.
August 1, 2024
Brachytherapy based microboosting to the dominant intraprostatic lesion in prostate cancer: A systematic review on treatment outcomes and toxicities.
August 1, 2024
Cancer centers of excellence for the multidisciplinary management of urologic cancers The intersection between education, research, and healthcare.
August 1, 2024
Exploring membranous NECTIN-4 expression patterns and enfortumab vedotin response in prostate cancer.
August 1, 2024
Comparison of data fusion strategies for automated prostate lesion detection using mpMRI correlated with whole mount histology.
August 1, 2024
Quantitative PSMA-PET parameters in localized prostate cancer: prognostic and potential predictive value.
August 1, 2024
Patient Perceptions of Standardized Risk Language Used in ACR Prostate MRI PI-RADS Scores
July 31, 2024
Combining PSMA-PET and PROMISE to Re-Define Disease Stage and Risk in Patients with Prostate Cancer: A Multicentre Retrospective Study
July 31, 2024
Page 11 of 1422
Start
Prev
6
7
8
9
10
11
12
13
14
15
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free